Is the evidence in favour of neoadjuvant chemotherapy in stage IIIA (N2) non-small cell lung cancer solid enough?

Research output: Contribution to journalArticleResearch

Original languageEnglish
Pages (from-to)305-310
JournalMonaldi Arch. Chest Dis.
Volume55
Publication statusPublished - 1 Jan 2000

Cite this